NCT02900131View on ClinicalTrials.gov

Efficacy, Safety and Dose Finding Trial of Topical Jaungo Application in Atopic Dermatitis Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 19, 2016

Primary Completion Date

March 16, 2017

Study Completion Date

March 16, 2017

Conditions
Dermatitis, Atopic
Interventions
DRUG

Jaungo

Participants in trial group 1 will apply Jaungo and placebo to the lesion once a day for three weeks. Participants in trial group 2 will apply Jaungo to the lesion twice a day for three weeks.

DRUG

Placebo

Participants in trial group 1 will apply Jaungo and placebo to the lesion once a day for three weeks. Participants in control group will apply placebo to the lesion twice a day for three weeks.

Trial Locations (1)

Unknown

Kyung Hee University Hospital, Seoul

All Listed Sponsors
lead

Kyung Hee University Hospital at Gangdong

OTHER

NCT02900131 - Efficacy, Safety and Dose Finding Trial of Topical Jaungo Application in Atopic Dermatitis Patients | Biotech Hunter | Biotech Hunter